LBA73SELPAC: A 3 arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)P Nathan, A Needham,P G Corrie,S Danson, J Evans,S Ochsenreither,S Kumar, A Goodman,J M G Larkin, I Karydis,N M Steven,P Lorigan,R Plummer,P Patel, H M Shaw,S Leyvraz, C Rawcliffe,E E Psarelli, L Handley,J J SaccoANNALS OF ONCOLOGY（2019）引用 11|浏览45暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
